Structural biology of antibody:antigen complexes
抗体的结构生物学:抗原复合物
基本信息
- 批准号:8329266
- 负责人:
- 金额:$ 25.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdjuvantAffinityAntibodiesAntibody AffinityAntigen-Antibody ComplexAntigensB cell repertoireBindingCharacteristicsCollaborationsComplexCryoelectron MicroscopyCrystallizationDevelopmentDevicesDissectionEpitope MappingEpitopesExposure toFoundationsGlycoproteinsGoalsImmune responseImmunizationImmunodominant EpitopesInactivated VaccinesInfectionInfluenza HemagglutininInstructionKnowledgeLeadLinkMapsMethodsMutationNaturePathway interactionsPositioning AttributePropertyProteinsResolutionRotavirusSamplingSeriesSpecificityStructureSurfaceTechnologyTestingVaccinationVaccinesViral AntigensVirusWorkX-Ray Crystallographybasedesigninfluenzavirusnovelparticlereconstructionresponsescaffoldstemstructural biologyvaccine development
项目摘要
The overall goals of Project 3 are to understand the high-resolution structural correlates of immunodominance
and to provide structural foundations for designing immunogens that can focus an immune response on
particular, chosen epitopes. Our principal hypothesis is that structural contributions to immunodominance can
be revealed by correlating structures of antibody-antigen complexes with knowledge of the repertoire from
which the antibody was derived and reconstruction of the mutational sequence that led to the affinity matured
antibody from its germline precursor. The high-throughput approaches described in Project 1 can give us the
required information about repertoire and about affinity maturation of antibodies denved from the settings of
vaccination vs. infection. We propose here to provide the corresponding three-dimensional information. We
have the following four Aims. [1) What are the structural characteristics of cross-reactive antibodies bound with
their HA epitopes? We will determine structures of selected representatives of the antibodies studied in projects
1 and 2, in complex with the relevant influenza virus HA. We will begin with standard crystallographic
approaches, but proceed as rapidly as possible to higher-throughput cryoEM methods (Aim 2; see also Core C).
(2) We will develop approaches for mounting "guest proteins" [with influenza HA as the principal target) onto
icosahedral-virus scaffolds, to create a symmetric array suitable for structure determination by cryoEM. We will
start with the rotavirus double-layer particle (DLP) as our scaffold, and the outer-layer glycoprotein, VP7, as the
mounting device.; we will also test the other outer-layer protein, VP4, as a trimeric mounting protein. [3) What
makes an epitope immunodominant? The opportunity afforded by the cryoEM approach to examine a
systematic and relatively unbiased set of complexes will allow us to determine the structural correlates of
immunodominance directly. We will determine structures of a selected HA in complex with antibodies
representing the entire spectrum of a typical repertoire as revealed by the studies in Project 1 and mapped by
Project 2. [4) Application to other viral antigens. We will apply to the mounting strategies developed in Aim 2 to
other viral antigens for which a combination of repertoire analysis and structural dissection might lead to novel
项目3的总体目标是了解免疫优势的高分辨率结构相关性
并为设计免疫原提供结构基础,
特定的,选择的表位我们的主要假设是,免疫优势的结构贡献,
通过将抗体-抗原复合物的结构与来自抗体-抗原复合物的库的知识相关联,
抗体的来源和导致亲和力成熟的突变序列的重建
抗体从其生殖系前体。项目1中描述的高通量方法可以为我们提供
所需的关于库的信息和关于抗体的亲和力成熟的信息,
疫苗接种与感染我们建议在这里提供相应的三维信息。我们
有以下四个目标。[1)结合的交叉反应性抗体的结构特征是什么
他们的HA抗原表位我们将确定项目中研究的抗体的选定代表的结构
1和2,与相关流感病毒HA复合。我们将开始从标准晶体学
方法,但尽可能快地进行更高通量的cryoEM方法(目标2;另见核心C)。
(2)我们将开发将“客体蛋白”(以流感HA为主要靶标)固定在
二十面体-病毒支架,以产生适合于通过cryoEM进行结构测定的对称阵列。我们将
首先,我们以轮状病毒双层颗粒(DLP)作为支架,外层糖蛋白VP 7作为支架,
安装装置。我们还将测试另一个外层蛋白VP 4作为三聚体安装蛋白。[3)什么
使表位具有免疫显性?cryoEM方法提供的检查
系统的和相对公正的一套复合物将使我们能够确定的结构相关的
免疫优势直接。我们将确定与抗体复合的选定HA的结构
代表了项目1中的研究所揭示的典型剧目的整个频谱,并由
项目2. [4)应用于其他病毒抗原。我们将应用目标2中开发的安装策略,
对于其它病毒抗原,库分析和结构解剖的组合可能导致新的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN COPLAN HARRISON其他文献
STEPHEN COPLAN HARRISON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN COPLAN HARRISON', 18)}}的其他基金
Structural biology of antibody:antigen complexes
抗体的结构生物学:抗原复合物
- 批准号:
8516984 - 财政年份:2013
- 资助金额:
$ 25.75万 - 项目类别:
Structural biology of antibody:antigen complexes
抗体的结构生物学:抗原复合物
- 批准号:
8377204 - 财政年份:2012
- 资助金额:
$ 25.75万 - 项目类别:
Discovery of small molecules to block fusion and entry of dengue and other env vi
发现小分子以阻止登革热和其他环境病毒的融合和进入
- 批准号:
8233434 - 财政年份:2011
- 资助金额:
$ 25.75万 - 项目类别:
Project 4: Structural Biology of Influenza Antibody-Antigen Interactions
项目4:流感抗体-抗原相互作用的结构生物学
- 批准号:
10549614 - 财政年份:2011
- 资助金额:
$ 25.75万 - 项目类别:
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
感染和疫苗诱导的 B 细胞库的结构功能分析
- 批准号:
10549602 - 财政年份:2011
- 资助金额:
$ 25.75万 - 项目类别:
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
感染和疫苗诱导的 B 细胞库的结构功能分析
- 批准号:
8303235 - 财政年份:2011
- 资助金额:
$ 25.75万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别: